Questcor Pharmaceuticals (QCOR) Slammed after Citron Notes Aetna Drops Acthar Coverage
Tweet Send to a Friend
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) is seeing downside after Citron Research notes that Aetna (NYSE: AET) is dropping coverage of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE